A lower level of FATS expression in breast cancer was associated with a higher nuclear grade (P = .01), and there were no correlations between FATS mRNA levels and other clinicopathologic factors including clinical stage, tumor size, lymph node status, ER status and PR status. Here, C10orf90 is linked to breast carcinoma.